Viewing Study NCT03731832


Ignite Creation Date: 2025-12-24 @ 9:57 PM
Ignite Modification Date: 2026-03-28 @ 8:13 PM
Study NCT ID: NCT03731832
Status: COMPLETED
Last Update Posted: 2025-09-30
First Post: 2018-10-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Pomalidomide, Ixazomib, and Dexamethasone With or Without Intensification by Cyclophosphamide in Relapsed or Refractory Multiple Myeloma
Sponsor: GWT-TUD GmbH
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Refractory Multiple Myeloma View
Keywords: